Integrin α9β1: a new target to fight thrombosis

Abstract

In this issue of Blood, Dhanesha et al explore the role of myeloid cell specific integrin a9b1 in arterial thrombosis.1 They demonstrate that genetic ablation or pharmacologic inhibition of the integrin reduces thrombosis and, importantly, this effect is not accompanied by impairment of normal hemostasis.